期刊文献+

达托霉素中间体结晶工艺研究 被引量:1

Crystallization Development of Daptomycin Intermediate
下载PDF
导出
摘要 达托霉素是世界上公认的万古霉素等现用抗生素的最佳替代品,其生产工艺尤其是提炼工艺较复杂,含有多步层析工艺,缺点是处理量小、溶媒量大、生产危险性高,急需进行工艺改进。本文研究开发了达托霉素中间体的结晶工艺,以替代目前使用的层析工艺,优势在于生产成本低,溶媒量小,处理量大,操作安全便捷,适合产业化应用。 Datomycin was one of the important products in antibiotic market. The traditional manufacturing process especially the refining process for preparation of dactomycin was fairly complex and it was urgent demand to find a better way to increase the volumetric capacity, reduce the amount of solvent and reduce operational risks. Thus we developed a crystallization method as an alternative to the current gel chromatography process. The new method was quite simple and suitable for industrialized production due to its low production cost, low amount of solvent, high performance and also very safe to operate.
作者 谢厅 许婷婷 周陈锋 方乐 张扬 赵旺林 XIE Ting;XU Tingting;ZHOU Chenfeng;FANG Le;ZHANG Yang;ZHAO Wanglin(Hangzhou Eastchina Pharmaceutical Company, Hangzhou 310011, China)
出处 《化工技术与开发》 CAS 2019年第9期22-24,共3页 Technology & Development of Chemical Industry
关键词 达托霉素 抗生素 结晶 工艺优化 datomycin antibiotic crystallization process optimization
  • 相关文献

参考文献4

二级参考文献59

  • 1Baltz R H,Miao V, Wrigley S ICNatural products to drug:daptomycin and related lipopeptide antibiotics [J].Nat Prod Rep, 2005;22(6):717-741
  • 2Hill J,Siedlecld J, Parr I, et al.Synthesis and biological activity of N- Acylated ornithine analogues ofdaptomycin[J].Bioorg Med Chem Lett,2003;13(23):4187-4191
  • 3Boaretti M, Canepari P.-Purificad-on ofdaptomycin binding proteins (DBPs) from the membrane of Enter ococcus kirae[J].New Microbiol, 2000;23:305-317
  • 4Schriever C A, Femandez C, Rodvold K A,et a.LDaptomycin:A novel cyclic lipopeptide antimicrobial[J].Am J Health syst Pharm, 2005;62(11):1145-1158
  • 5Silverman J A, Perlmutter N G, Shapiro H M.Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus atzreus [J].Anfimicrob Agents Chemother, 2003;47(8):2538-2544
  • 6Barry AL, Fuchs PC,Brown SD.In vitro activities of daptomycin against 2789 clinical isolates from 11 North American medical centers [J]. Antimicrob Agents Chemother,2001; 45(6):1919-1922
  • 7Streit JM,Jones RN, Sader HS.Daptomycin activity and spectrumaworldwide sample of 6737 clinical gram-positive organisms[J]J antimicrob Chemother.2004;53 (4):669-674
  • 8Safdar N, Andes D, Craig WA.In vivo pharmacodynamic activity of daptomycin[J].Antimicrob Agents Chemother, 2004;48(1):63-68
  • 9Alder JD.Daptomycin,a new drug class for the treatment of Gam -postive in functions [J].Drugs Today,2005;41(2):81-90
  • 10Mohan SS, McDermott BP, Cunha BA.Methicinin-resistant Staphylococcus aureus prosthetic aortic valve endocardids with paravalvular abscess treated with daptomycin[J].Heart Lung, 2005;34:69-71

共引文献17

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部